Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01344226 · ClinicalTrials.gov registry record
Clinical Outcomes and Evaluation of Lotemax 0.5% in Treatment of Ocular Inflammation Associated With Cataract Surgery
A clinical trial, sponsored by Toyos Clinic.
- Completed
- Registry status
- 49
- Enrollment target
NCT01344226 is a clinical trial that has completed, run by Toyos Clinic. The registered enrollment target is 49 participants.
The verdict
NCT01344226 has completed, sponsored by Toyos Clinic.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
Investigate the intraocular pressure(pressure inside the eye) of patients who are treated with Lotemax after undergoing cataract surgery.
Interventions
- DRUG loteprednol 0.5% ophthalmic solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01344226
The ClinicalTrials.gov registry entry for NCT01344226 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Toyos Clinic, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which loteprednol 0.5% ophthalmic solution is the first listed.
NCT01344226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01344226 about?
NCT01344226 is a clinical study titled "Clinical Outcomes and Evaluation of Lotemax 0.5% in Treatment of Ocular Inflammation Associated With Cataract Surgery". Investigate the intraocular pressure(pressure inside the eye) of patients who are treated with Lotemax after undergoing cataract surgery.
What is the current status of trial NCT01344226?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2011-04. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01344226?
The interventions under investigation include: loteprednol 0.5% ophthalmic solution (DRUG).
Who is sponsoring clinical trial NCT01344226?
This trial is sponsored by Toyos Clinic, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.